SCHEMBL8545394

SCHEMBL8545394

O=C(CCl)C1CCC2CCCC21

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21085336 0.92 PEPD (0.33)
SCHEMBL13332859 0.80 CYP2D6 (0.33)
SCHEMBL9539732 0.79 IDH1 (0.34)
SCHEMBL17237808 0.75 TSHR (0.37) POLB
SCHEMBL17237810 0.75 TSHR (0.37) POLB
SCHEMBL2277633 0.74 SLC1A2 (0.39)
SCHEMBL11597749 0.74 SLC1A2 (0.39)
SCHEMBL504028 0.74 SLC1A2 (0.39)
SCHEMBL504027 0.74 SLC1A2 (0.39)
SCHEMBL3706333 0.72 EPHX1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0564924-B1 2-Oxoethyl derivatives as immunosuppressants BAYER AG (US) 1998-09-09 EP disclosed
US-5686424-A FOR TREATING INFLAMMATION MILES INC. (US) 1997-11-11 US disclosed
EP-0564924-A2 2-Oxoethyl derivatives as immunosuppressants Bayer Corporation (US) 1993-10-13 EP disclosed